ロード中...
Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
Quadrivalent human papillomavirus (4vHPV) vaccine was licensed for use in the United States in 2006 and through 2015 was the predominate HPV vaccine used. With the exception of syncope, a known preventable adverse event after any injected vaccination, both pre-licensure and post-licensure 4vHPV safe...
保存先:
| 出版年: | Hum Vaccin Immunother |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4964727/ https://ncbi.nlm.nih.gov/pubmed/27029786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1168952 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|